Wolverine Trading
RPRX

Wolverine Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Wolverine Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18,946
Closed -$40K – 5822
2016
Q3 		$40K Buy
+18,946
New +$37.5K ﹤0.01% 4430

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Trading's RPRX Position: Q4 2016 in Review

Wolverine Trading sold out of Repros Therapeutics Inc. (RPRX) in Q4 2016, closing a stake of 18,946 shares — an estimated $40K sold.

Wolverine Trading first reported a position in RPRX in Q3 2016 and held it in 1 quarter. The position peaked at $40K in Q3 2016. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

  • Wolverine Trading reported no remaining Repros Therapeutics Inc. position as of Q4 2016 after selling out during the quarter.
  • Wolverine Trading sold 18,946 Repros Therapeutics Inc. shares in Q4 2016, an estimated $40K.
  • Wolverine Trading first reported a position in Repros Therapeutics Inc. in Q3 2016 and held it in 1 quarter.
  • Wolverine Trading's Repros Therapeutics Inc. position peaked at $40K in Q3 2016.
  • 43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on Wolverine Trading's 13F filing for Q4 2016, filed 14 Feb 2017.